Literature DB >> 11063041

Clinical approach to fecal soiling in children.

V Loening-Baucke1.   

Abstract

Fecal soiling is common in childhood and can be caused by stool toileting refusal, fecal incontinence due to organic disease, or encopresis due to functional constipation. Anatomical, neurologic, and inflammatory causes for fecal soiling are ruled out by history and physical examination and, if necessary, by anorectal manometry, barium enema, and rectal biopsy. The initial treatment suggestion for children with stool toileting refusal is to put the child back into pull-ups or diapers. Most children with fecal soiling due to organic disease continue with some degree of incontinence despite optimal medical management. Antegrade enema administration helps those with severe fecal incontinence due to organic causes who do not respond to medical management. Successful treatment of constipation and encopresis requires a combination of medical therapy, nutritional intervention, behavioral intervention, and long-term compliance with laxative use. The combined treatment approach improves the constipation and encopresis in all patients who comply with the treatment program. In some children, cow's milk protein intolerance may be the cause. In them, cow's milk protein needs to be eliminated.

Entities:  

Mesh:

Year:  2000        PMID: 11063041     DOI: 10.1177/000992280003901005

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  2 in total

1.  MACE or caecostomy button for idiopathic constipation in children: a comparison of complications and outcomes.

Authors:  S Cascio; M E Flett; M De la Hunt; A M Barrett; B Jaffray
Journal:  Pediatr Surg Int       Date:  2004-06-22       Impact factor: 1.827

2.  Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study.

Authors:  Narayanan Venkatasubramani; Colin D Rudolph; Manu R Sood
Journal:  BMC Gastroenterol       Date:  2008-08-21       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.